Prior studies reported a 2–5-fold higher risk of glucose metabolism disorders in PCOS (11, 12, 18), suggesting a shared pathophysiologic background in insulin action and secretion (7, 27, 28). The gene discussed is INS; the disease is polycystic ovary syndrome.